Present contraceptive technology may not be adequate to allow family planning to be successfully practised on a world-wide scale. The limitations of current methods of fertility regulation and service systems are outlined. The development of better technology poses challenging problems. WHO's Special Programme of Research and Research Training in Human Reproduction represents an interdisciplinary and international approach to their solution.
Get full access to this article
View all access options for this article.
References
1.
NationsUnited, The population debate: dimensions and perspectives. Papers of the World Population Conference, Bucharest. 1974, Vol. II. United Nations, New York(1975).
2.
OmranA. R. and StandleyC. C., Family Formation Patterns and Health. World Health Organization, Geneva (1976).
3.
NationsUnited, The population debate: dimensions and perspectives. Papers of the World Population Conference, Bucharest, 1974, Vol. I. United Nations, New York(1975).
4.
GreepR. O., KobiinskyM. A. and JaffeF. S., Reproduction and Human Welfare: a Challenge to Research, MIT Press, Cambridge (1976).
5.
McNamaraR. S., An address onReduction of Fertility, MIT Press, Cambridge(28 April1977).
6.
Royal College of General Practitioners, Oral Contraceptives and Health, Pitman, London (1974).
7.
VesseyM. P. and DollR., Evaluation of existing techniques. Proc. R. Soc. London Ser. B, 195, 69–80 (1976).
8.
Royal College of General Practitioners, Mortality among oral contraceptive users. Lancet ii, 727–731 (1977).
9.
ReportsPopulation, Debate on Oral Contraceptives and Neoplasia Continues, No. 4 (May1977).
10.
VesseyM. P. et al., Mortality among women participating in the Oxford/Family Planning Association contraceptive study. Lancet11, 731–733 (1977).
11.
HefnawiF. and SegalS. J.(eds.), Analysis of Intrauterine Contraception, North-Holland Publishing Co., Amsterdam (1975).
12.
MarshallJ. F. and PolgarS.(eds.), Culture, Natality and Family Planning, University of North Carolina (1976).
13.
World Health Organization, Sixth Annual Report of the Special Programme of Research, Development and Research Training in Human Reproduction. WHO offset document (1977).
14.
CampbellA. A. and BerelsonB., Contraceptive specifications. Stud. Fam. Plann. 2. 14–19 (1971).
15.
CucaR. and PierceC. S., Experimentation in family planning delivery systems, Johns Hopkins University Press, Baltimore (1977).
16.
BygdemanM and BergströmS., Prostaglandins as abortifacients: a summary of ten years’ experience. In Obstetric and Gynaecological Uses of Prostaglandinsed. byKarimS. M. M., Proceedings of the First Inter-Congress Asian Federation of Obstetrics and Gynaecology, April1976, Eurasia Press (1976).
17.
World Health Organization, Development of Vaccines for Fertility Regulation, Scriptor, Copenhagen (1976).
18.
BriggsM. H. and DiczfalusyE.(eds.), Pharmacological Models in Contraceptive Development. Proceedings of aWHO Symposium, Geneva, 1973. Forum, Copenhagen (1974).
19.
DjerassiC., Prognosis for the development of new chemical birth-control agents. Science166, 468–473 (1969).
20.
DiczfalusyE. and StandleyC. C., The Use of Non-human Primates in Research on Human Reproduction: Proceedings of a WHO Symposium, Sukhumi, 1972, Forum, Copenhagen(1972).
21.
DjerassiC., Birth control after 1984. Science169, 941–951 (1970).
22.
MishellD. R., Design of studies for the assessment of contraceptive drugs and devices. In Regulation of Human Fertility, Proceedings of aWHO Symposium, Moscow, 1976, ed, by E. Diczfalusy, pp. 236–252. Scriptor, Copenhagen (1977).
23.
KesslerA. and StandleyC. C., Research training in the biomedical aspects of human reproduction and family planning in developing countries. Contraception13, 469–477 (1976).
24.
KesslerA. and StandleyC. C., Human reproduction and family planning: research strategies in developing countries. Nature (London)251, 577–579 (1974).
